News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results